Larotrectinib in adult patients with solid tumours: a multi-centre, open-label, phase I dose-escalation study.
Hong DS, Bauer TM, Lee JJ, Dowlati A, Brose MS, Farago AF, Taylor M, Shaw AT, Montez S, Meric-Bernstam F, Smith S, Tuch BB, Ebata K, Cruickshank S, Cox MC, Burris HA 3rd, Doebele RC.
Hong DS, et al.
Ann Oncol. 2019 Feb 1;30(2):325-331. doi: 10.1093/annonc/mdy539.
Ann Oncol. 2019.
PMID: 30624546
Free PMC article.
Clinical Trial.